Estrogen Receptor Positive (ER+) Breast Cancer – Market Insights, Epidemiology and Market Forecast-2023_United States

Date: 2016-05
Pages:60
Price:

“Estrogen Receptor Positive (ER+) Breast Cancer – Market Insights, Epidemiology and Market Forecast-2023- US” Reports provides an overview of the disease and global market size of the Estrogen Receptor Positive (ER+) Breast Cancer for the United States. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Estrogen Receptor Positive (ER+) Breast Cancer from 2013-2023. According to DelveInsight, the forecasted patient population of ER+ breast cancer will increase at a CAGR of 2.03% from 2015 to 2023 and the worldwide ER+ breast cancer market is estimated to be 2.86 billion by 2023. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Note: This report will be delivered to the client in 48 hours

Scope
• Report covers the disease overview, current treatment options, prescription drugs and emerging therapies.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States from 2013-2023.
• It also provides Market size of Estrogen Receptor Positive (ER+) Breast Cancer for United States and forecasted Market size to 2023.

Categories

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample